Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 33.21% is 173% above its 5-year average of 12.18%, near the low end of its 5-year range (0.00%–156.86%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.75% above its 12-month average of 23.43%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 33.21%.
DEBT TO ASSETS RATIO
33.21%
DEBT TO ASSETS RATIO AVG TTM
23.43%
DEBT TO ASSETS RATIO AVG 3Y
20.23%
DEBT TO ASSETS RATIO AVG 5Y
12.18%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+41.75%
CURRENT VS 3Y AVG
+64.16%
CURRENT VS 5Y AVG
+172.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+36797.47%
vs the sector median at left
Silexion Therapeutics Ltd.
Market Cap
$106970.00
Debt to Assets Ratio
33.21%
TTM Avg
23.43%
3Y Avg
20.23%
5Y Avg
12.18%
Market Cap
$95475.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$71053.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30054.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6235.00
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$378849.00
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Silexion Therapeutics Ltd. (SLXN) | $106970.00 | 33.21% | 23.43% | 20.23% | 12.18% |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 0.00% | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $71053.00 | 0.00% | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61172.00 | 2.89% | N/A | N/A | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | 0.00% | N/A | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30054.00 | 0.01% | N/A | N/A | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6235.00 | 0.15% | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $252756.00 | 0.05% | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | 0.05% | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | 0.18% | N/A | N/A | N/A |
Debt/Assets
33.2%
Debt/Equity
32.05
Current Ratio
0.94
Interest Coverage
894.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 33.21% |
| 2026-03-31 | 9.47% |
| 2025-12-31 | 6.49% |
| 2025-09-30 | 4.18% |
| 2025-06-30 | 63.79% |
| 2025-03-31 | 41.91% |
| 2024-12-31 | 156.86% |
| 2024-09-30 | 139.68% |
| 2024-06-30 | 4.59% |
| 2024-03-31 | 4.02% |
| 2023-12-31 | 3.25% |
| 2023-09-30 | 43.93% |
| 2023-06-30 | 7.68% |
| 2023-03-31 | 5.95% |
| 2022-12-31 | 2.90% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
